09/09/2026
As a New Hampshire-based wealth management firm, we're always interested in developments that strengthen the communities we serve.
United Therapeutics acquisition of the former Anheuser-Busch property in Merrimack represents a significant investment in the state. The $47 million acquisition has the potential to bring hundreds of high-paying jobs and further expand New Hampshire's growing biotech presence.
Continued private investment like this creates opportunities for employees and local businesses while having the potential to strengthen New Hampshire's broader economy.
Biotechnology firm United Therapeutics Corporation has acquired the former Anheuser-Busch brewery site in Merrimack for $47 million, according to sources familiar with the matter.